Objective: To assess the feasibility, strengths and weaknesses of using administrative data to compare hospital performance across countries, using mortality after coronary artery bypass graft (CABG) surgery as an illustrative example. Methods: Country specific and pooled models using individual-level data and logistic regression methods assess individual hospital performance using funnel plots accounting for multiple testing. Outcomes are adjusted for age, sex, comorbidities and indicators of patient severity. Data includes patients from all publicly funded hospitals delivering CABG surgery in England and Spain. Inpatient hospital-level standardized mortality rates within 30 days of CABG surgery are calculated for 83 999 CABG patients between 2007 and 2009. Results: Unadjusted national mortality rates are 5% in Spain and 2.3% in England. Country-specific models identified similar patterns of excess mortality 'alerts' and 'alarms' in hospitals in Spain or England. Pooling data from both countries identifies larger numbers of alerts and alarms in Spanish hospitals, and risk-adjustment increased the already large national mortality difference. This was reduced but not eliminated by accounting for lower volume in Spanish hospitals. Conclusion: Cross-national comparisons potentially add value by providing international performance benchmarks. Hospital-level analysis across countries can illuminate differences in hospital performance, which might not be identified using country-specific data or incomplete registry data, and can test hypotheses that may explain national differences. Difficulties of making data comparable between countries, however, compound the usual within-country measurement problems.
Introduction
Measuring and monitoring variations in the quality of health-care provision by comparing quality indicators can generate important insights into the performance of clinicians, hospitals and health-care systems. In a number of countries, efforts have been made to identify 'unwarranted' variations in health care. Methods of analysing variations have been developed most notably since the 1970s by the Dartmouth Atlas team, 2 but are also being used in many other settings, including the Atlas de Variaciones en la Práctica Médica in Spain 3 and the NHS Atlas of Variation in England. 4 Comparisons of health-care quality between countries are generally made using national aggregates from pooled administrative data 5 or pooled registry data in individual clinical areas. 6 Clinical registry data, such as the European Association for Cardio-Thoracic Surgery (EACTS) database, 6 have advantages over administrative data in principle: more detailed clinical information is available that can permit a more sophisticated approach to risk-adjustment. But in practice, clinical registries remain voluntary and incomplete, and therefore potentially suffer from serious selection bias. In contrast, our data source in both countries is routinely collected administrative data on all episodes of care in the public health system so is not subject to selection bias. Despite global interest in improving medical care, and long-standing interest in exploring unwarranted variations between as well as within countries, 7 efforts to make more detailed internationally comparable data available have been limited. 8 The European Collaboration for Healthcare Optimisation (ECHO) project is an international effort to bring together comprehensive record-level patient data on virtually all patients treated in public hospitals from six European countries in order to compare the availability, quality and efficiency of care across countries at detailed sub-national organizational and geographical levels. This includes assessment of hospital performance using carefully constructed condition-specific indicators of the quality of care.
In this article, we explore the opportunities and challenges resulting from hospital-level comparisons across countries, using as a case study mortality rates after coronary artery bypass graft (CABG) surgery in England and Spain. Mortality after CABG is widely used as a quality indicator, including by the US Agency for Healthcare Research and Quality (AHRQ) Inpatient Quality Indicators (IQI#12), which states its rationale: CABG is a relatively common procedure that requires proficiency with the use of complex equipment; and technical errors may lead to clinically significant complications, such as myocardial infarction, stroke, and death. Better processes of care may reduce mortality for CABG, which represents higher quality care. 9 CABG mortality rates differ substantially between countries, as illustrated by EACTS in 2010. 6 Risk-adjusted death rates for CABG in the NHS in England and Wales were reported as '25% better than the European average'. 10 In this article, we use patient-level data within and between two countries to assess the added value of pooling administrative data across countries and to explore hypotheses that may explain differences such as those reported in cardiac care. These may be driven by a small number of hospitals with unacceptably high mortality rates (perhaps due to coding differences or under-performance). Otherwise, country differences in outcomes may be explained by the concentration of services into specialist centres with differences in clinical facilities and staff experience, as reflected by hospital volume of surgery. These hypotheses cannot be tested adequately using within-country data or national aggregates, but lessons may potentially be learned from hospital-level comparisons across countries using comprehensive administrative data.
Data and methods
This study uses data on all publicly funded patients undergoing CABG surgery in Spain (ICD-9-CM procedure codes 3610-3619) and England (OPCS4 procedure codes K40-K46) during the period 2007-2009. Based on the AHRQ indicator IQI#12, 9 data were extracted from administrative databases in Spain (Conjunto Mínimo Básico de Datos al Alta Hospitalaria & Cirugía Mayor Ambulatoria) and England (Hospital Episodes Statistics). Condition-specific standardized mortality ratios (SMRs) were calculated for each hospital, defined as the number of observed inpatient deaths over the number of 'expected' in-patient deaths (after adjusting for age, gender, other procedures and comorbidities) up to 30 days following admission. A value of one corresponds to expected performance, whereas a value above one indicates higher than expected mortality. Patients who were discharged or were still in hospital at 30 days after admission were defined as 'survivors'. The number of expected deaths was predicted by logistic regression models that took into account patient age group, gender, and interactions between age and gender, as well as comorbid conditions as defined by the Elixhauser index 11, 12 and year of admission. We also included measures of the severity of the underlying condition. Although not all risk factors for mortality after CABG are available in administrative datasets, 13 our severity indicators included primary diagnosis of acute myocardial infarction, and whether this was classified as with ST segment elevation (STEMI), non-STEMI or unclassified. Myocardial infarction is a risk factor, but could also be a complication of surgery. We therefore included myocardial infarction only as a primary diagnosis, but also tested the model without it, and it makes little material difference to the findings. We also included whether the patient underwent heart valve replacement and/or implantation of a cardiac or circulatory assistance device, and whether the intervention was major structural surgery (including repair or revision of atrial and ventricular septa, cardiotomy, pericardiotomy, pericardiectomy and excision of a lesion of the heart). The codes for these severity indicators are reported in the online supplementary material. Emergency admission was not in the baseline model as we were concerned that coding was incomparable, but again we tested the model including it, and it makes little material difference to the findings.
All standard errors are adjusted for clustering at the hospital level. All risk-adjustment models were estimated with and without an indicator variable for the country of treatment. Hospitals were excluded if they treated fewer than 50 patients in any year. Inclusion of a country-level effect was used to explore potential explanations for the difference by tracking the change in estimated country risk difference after accounting for potential confounding factors such as volume of surgery. This was not included in creating funnel plots for hospitals from the pooled data.
Funnel plots were used to assess whether a hospital's SMR following CABG surgery is statistically significantly different from the expected outcome.
14 To do this, SMRs are plotted against a measure of their precision, so that the control limits form a 'funnel' around the target outcome. The control limits are calculated to reflect 95% and 99.8% significance levels, and are adjusted for multiple testing using the false discovery rate correction. 15 Hospitals outside the 99.8% control limit are identified as 'alarms', whereas those between the 95% and 99.8% control limit are classified as 'alerts'. 16 For the purpose of this analysis, we focused on negative performance deviations, i.e. SMRs above what would be expected. All analyses were conducted and graphs produced using Stata version 12.
Results
Descriptive statistics are presented in table 1. Eighty-four thousand nine hundred twenty-one admissions involving CABG surgery were Difference in overall procedure rates reflects real apparent differences in clinical practice, not coding or other errors. OECD 16 reports 37 CABGs per 100 000 population in England and 17 per 100 000 in Spain. See online supplementary material for definition of procedures.
recorded for the 3-year period: 63 294 in England and 21 627 in Spain. This difference in intervention rates is consistent with other data sources; for example, OECD health data reports that on average Spain conducts 17 CABG procedures per 100 000 population, compared with 37 per 100 000 in UK. 16 Twenty observations (0.05%) were excluded due to missing values in one or more variables. A further 902 (1.1%) were excluded because the hospital treated fewer than 50 patients per year. The final sample consisted of 83 999 observations. The overall crude mortality rates are 2.3% in England and 5.0% in Spain. Both patient populations were very similar in terms of the age structure and patient gender. England appeared to treat patients with fewer Elixhauser comorbidities (or to code comorbidities in less detail). Spain had more patients with a myocardial infarction (particularly with ST elevation) and England was less likely to code whether myocardial infarction was ST elevated or not, so had more 'unspecified' MI cases. The effect of this on riskadjustment, however, is minimal, given that the risk of death associated with STEMI and nSTEMI appears to be very similar [the odds ratio (OR) for both is 1.28, see table 2] . Figure 1 shows unadjusted hospital-level mortality rates following CABG surgery, demonstrating a considerable difference between hospitals (particularly in Spain) and between countries. Table 2 summarizes the findings, with two different approaches to riskadjustment. The first column (Model 1) illustrates a very simple Figure 1 Unadjusted mortality rates following CABG surgery 3-year average in England and Spain. Unadjusted mortality rate following CABG surgery demonstrates a considerable difference between hospitals (particularly in Spain) and between countries (average mortality is 2.3% in England, 5.0% in Spain) Figure 2 shows case-mix adjusted hospital SMRs for CABG surgery by expected number of deaths (i.e. hospital volume of surgery multiplied by the average expected mortality rate), using traditional within-country comparisons to demonstrate variations in hospital quality. Alerts are raised (exceeding the upper 95% control limits) in five hospitals in Spain and seven in England. One hospital in Spain and two in England raise alarms (exceeding the 99.8% control limit). Note that while the pattern appears similar, the average mortality rate is substantially lower in England than in Spain. Figure 3 illustrates the 'ECHO approach' to comparisons, with data from both countries being pooled. Several features in this graph are noteworthy. First, the hospitals' performance contrasts substantially with the traditional within-country findings. Nine Spanish hospitals are identified as 'alarms' in the pooled assessment compared with five in the country-specific assessment. Thirteen Spanish hospitals are additionally identified as 'alerts' that were within the normal range when considering Spain alone. Four English hospitals are now identified as alerts and none is assigned alarm status. Second, there is a clear separation in the number of expected deaths between English and Spanish hospitals, reflecting differences in volume across countries. The median hospital surgical volume in Spain is 154 patients a year, compared with 690 in England, and the highest volume hospital in Spain treated 337 patients in 1 year, whereas the lowest volume hospital in England treated 327. Third, despite the large overall betweencountry difference, the vast majority of hospitals in England and around a third of those in Spain lie within or below the 95% funnel and are largely comparable in terms of their SMR.
To explore whether country differences can be explained by outlier hospitals, by differences in volume, or by differences in coding intensity, we performed further sensitivity analyses (see table 3 ). First, we removed the 'alarms' in case these represented coding differences or extreme differences in patient risks not captured by our adjustment, and the country-level difference remained (OR: 2.17; 95% CI: 1.70-2.77). Second, we included hospital surgical volume as a control variable. We do not include this in our baseline model as this is an organizational difference that can be influenced by policy, rather than a patient-level difference that cannot. The effect of hospital volume (modelled as a continuous variable, 1000/ˇvolume) was significant (OR: 1.02; 95% CI: 1.003-1.04). There is no potential to model a threshold minimum volume as there is no overlap between hospital volume in England and Spain. Including hospital surgical volume reduced the 'Spain effect' to an OR of 1.71 (95% CI: 1.03-2.82). Finally, we reestimated the model controlling for the median number of Elixhauser comorbidities that are coded in each hospital. This accounts for the apparently higher levels of coding in Spain compared with England, and it increases the OR to 2.97 (95% CI: 2.37-3.73).
Discussion
This case study demonstrates a number of potential advantages to comparing hospital quality across countries using patient-and hospital-level administrative data, rather than country-level aggregates, but it also highlights a number of challenges.
The advantages of this approach relate to the additional information gleaned from hospital-level analysis using comprehensive data. Cross-country differences in mortality following CABG surgery favouring England have been reported previously from the EACTS database of registries across Europe. 6 This is a detailed data source, permitting a sophisticated approach to risk-adjustment, but it is incomplete and potentially suffers from serious selection bias. In particular, while England submitted over 340 000 records of cardiothoracic operations over the period 2006-2008, Spain, with a similar population size, submitted only 16 500. Our data source in both countries is routinely collected administrative data on all episodes of care in the public health system, so is not subject to selection bias. In practice, age and sex are likely to be the most important explanatory factors in most risk-adjustment processes. Exploring the accuracy (discrimination ability), our model generated an area under the receiver-operating curve of 0.703 just including age, sex, year and country, and 0.857 by adding all other risk-adjustments. This can be interpreted as 'fair' accuracy for the simple model and 'good' for the full risk-adjustment. Risk-adjustment remains contentious. For example, the original EuroSCORE I model, which used registry data 
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European Journal of Public Health to adjust for cardiac risk, was found to over-predict mortality by a factor of two, 17 reducing the likelihood of detecting outlier hospitals. 18 It is necessary to be cautious when using funnel plots and standardized mortality rates when mortality rates are relatively small. 19 Our model uses pooled data over 3 years and also focuses on identifying differences between countries as well as within them. Our approach to combining hospital-level data has advantages, in particular where there are country-level differences that would not be apparent in within-country checks. This is illustrated by different hospital volumes of surgery in England and Spain, which could potentially be a driver of hospital quality, although this may reflect either a minimum appropriate volume or a general volume-quality relationship. The difference in hospital volume between England and Spain may result from the decentralized nature of health-care provision in Spain and merits further research to determine whether the country-level difference is partly explained by hospital volume.
Aggregate differences between England and Spain result partly but not exclusively from apparently high mortality hospitals in Spain. But figure 3 illustrates that some of the lowest mortality hospitals are also in Spain, and many hospitals in both countries are within the expected range of mortality rates.
Pooled data reveals additional alerts and alarms, in this case in Spain, as the overall average mortality rate decreases. Comparing figure 2 (a within-Spain comparison) with figure 3 (pooled England and Spain) raises alerts in an additional eight hospitals and alarms in an additional seven hospitals in Spain. The addition of Spanish data to English data also resulted in two hospitals in England moving from the outer to the inner control limit, and five hospitals moving to within the expected range. It may be appropriate, therefore, to use the more challenging of the two targets for each country-in this case, the pooled data for Spain and national data for England.
This case study also highlights some notable challenges to the use of hospital quality data across countries. First, there may be cross-country differences in coding. CABG is a well-defined procedure and has straightforward procedure codes, despite the different coding systems in each country. The numbers of recorded secondary diagnoses are also, on average, similar in England and Spain, which means that our comorbidity adjustments should be comparable. Nevertheless, coding differences may remain, which could in principle affect our riskadjustment procedure. We explored this for hospital-level differences in coding and found coding intensity to be associated with outcomes.
Second, there may be differences in underlying patient risks that are not reflected in our risk-adjustment, for example populationlevel differences, or differences in the severity of the underlying condition. EACTS 6 found differences between the two countries in a number of factors, not all of which can be included in our riskadjustment process. Factors which have been accounted for include age, sex and number of comorbidities (e.g. diabetes and arteriopathy both predict mortality rates). We also included a primary diagnosis of acute myocardial infarction, including classification into STEMI and nSTEMI where possible, and a number of additional procedure codes in our risk-adjustment model as they were also found to be associated with mortality. But some potential confounders reported by EACTS cannot be included due to absence of routinely collected data. These include factors that reflect underlying patient populations (e.g. body mass index); severity of the underlying condition (e.g. the proportion of patients with a good ejection fraction or the number of grafts required); and severity of the comorbidities. Nonetheless, our analysis confirms findings from the registry data analysis in terms of England having lower mortality from CABG surgery, and given the large sample size in this analysis, it is extremely unlikely that unobserved differences explain the national-level difference.
We also explored whether the observed country differences in mortality are a result of the rather broad definition of the AHRQ indicator, which allows concomitant procedures such as heart valve replacement. As expected, we found that the crude mortality rate for isolated CABG is lower (0.7% in England and 2.5% in Spain), but the large country differences remained even after case-mix adjustment (OR 2.95, 95% CI 2.15-4.05). Full results are available on request.
A regression-based approach to risk-adjustment may not be sufficient to adjust for different covariate distributions across countries. We therefore also explored propensity score matching in order to balance patients in each country on the basis of their observed covariates. 20 In this approach, each Spanish patient is assigned one English patient or more (sampled with replacement) who is similar in terms of his or her characteristics. We considered nearest neighbour matching (one and three neighbours) and radius matching using a calliper of 0.2 times the standard deviation of the logit of the propensity score. The results of the matching exercise generally confirmed the findings of the regression analysis, with a mortality difference of 2.2% (Spain: 5.0%, England (matched): 2.8%; OR 1.84, 95% CI 1.56-2.18; based on three nearest neighbours matching) in favour of England. Results were robust to the choice of matching approach. Again, full results are available on request.
Finally, there may be differences in choice of procedures between hospitals for similar patients. For example, the proportion of surgeries performed off-pump varies between countries and appears to be associated with differences in mortality rates, although this may reflect patient selection. Perhaps of most concern, there may be national-level differences in the choice of treatments for similar conditions, and the choice between CABG surgery and percutaneous coronary interventions (PCI) is not entirely agreed upon. 21, 22 If, for example, some hospitals or surgeons in Spain are more likely to use PCI than CABG for similar patients, the patients receiving a CABG may be more severe, and therefore apparent differences in mortality rates may result from differences in patient risk rather than hospital quality. This may translate into different rates of intervention, which appear to exist between England and Spain, as in our dataset (and in OECD data) 16 there were substantially fewer CABG procedures per head of population in Spain compared with England over this period. The rate of CABG surgery varies substantially between countries, and OECD reports that Belgium carries out 125 per 100 000 population, compared with 37 per 100 000 in UK. The average rate for OECD is 49 per 100 000 and Spain appears to have the lowest rate, at 17 per 100 000. 16 This difference cannot be explained by population differences and may be considered as 'unwarranted' variation in clinical practice. However, we have investigated the possible selection of more severe cases for CABG in Spain, in particular exploring associations between CABG mortality and PCI mortality and can find no evidence that this form of selection explains any of the mortality difference.
All of these challenges to analysing hospital performance using routine data apply to within-country hospital comparisons, 23 but their effects may be compounded across countries and serve to encourage improvements in data comparability, both within and between countries.
Unanswered questions
We did not include volume of surgery as part of our baseline riskadjustment process as it is amenable to policy change (e.g. by concentrating services) rather than reflecting true differences in patient populations. But in a secondary analysis, we found that volume (modelled as a continuous effect) is a significant predictor of mortality. We are unable to explore a threshold volume effect as it is impossible to separate out 'low volume' hospitals from a 'Spain' effect, given that all Spanish hospital volumes are lower than all English volumes over this period. This secondary analysis demonstrates the potential of cross-country comparisons using administrative data, as it is possible to explore organizational phenomena and separate out the effect of different factors that contribute to a country-level difference.
Study implications
Overall, this case study demonstrates the substantial potential for cross-country comparisons of hospital performance. But given the challenges of cross-country comparisons and the limitations of our data, we think that these explorations should be viewed as prompts to explore data collection and coding procedures, and raise questions for researchers, policy makers, clinicians and managers, rather than providing definitive comparisons of hospital performance. The first implication is therefore that we should ensure better collection and reporting of comparable data, to improve understanding of the characteristics that contribute to the level of variation in the CABG mortality we observe. Hospitals with higher than expected mortality rates, particularly the small number of hospitals where rates exceed the upper 99.8% or 95% confidence intervals, should be challenged to examine the accuracy of their coding practices, and explore any extraordinary circumstances that may exist at hospital level. Following this, if differences cannot be explained, then pathways and processes of care and clinical practice, both surgical practice and post-acute care, should be examined in more detail. Hospitals with lower than expected mortality rates should also be examined to identify any differences in process and spread best practice.
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Key points
Unadjusted 30-day inpatient mortality after coronary artery bypass graft surgery is nearly twice as high in Spain as in England. Standard within-country comparisons identify patterns of excess hospital mortality that are similar in Spain and England. Poor performance ('alarms') in several Spanish hospitals is only visible using an international comparison. Mortality differentials cannot be explained by observed case-mix, coding depth or poorly performing hospitals alone. Spanish hospitals operate on a smaller scale than English ones, thus suggesting that volume may be a driver of country differences.
